Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Joh, Daniel Y ^a   Sun, Lova ^a   Stangl, Melissa ^a   Al Zaki, Ajlan ^b   Murty, Surya ^a   Santoiemma, Phillip P ^a   Davis, James J ^a   Baumann, Brian C ^a   Alonso Basanta, Michelle ^a   Bhang, Dongha ^c   Kao, Gary D ^a   Tsourkas, Andrew ^b   Dorsey, Jay F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; GOLD NANOPARTICLE; MACROGOL; GOLD; NANOPARTICLE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; RADIOSENSITIZATION; ANIMAL; BRAIN; BRAIN NEOPLASMS; DRUG EFFECTS; NUDE MOUSE; PATHOLOGY; RADIATION RESPONSE; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALIA; MUS;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; FEMALE; GLIOBLASTOMA; GOLD; MICE; MICE, NUDE; NANOPARTICLES;

EID: 84877000537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062425     Document Type: Article

References (58)

1. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, et al. (2007) Long-term survival with glioblastoma multiforme. Brain 130: 2596-2606.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
3. Schneider S, Ludwig T, Tatenhorst L, Braune S, Oberleithner H, et al. (2004) Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol 107: 272-276.
4. Papadopoulos MC, Saadoun S, Woodrow CJ, Davies DC, Costa-Martins P, et al. (2001) Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathol Appl Neurobiol 27: 384-395.
5. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, et al. (2003) Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105: 586-592.
6. Weiss N, Miller F, Cazaubon S, Couraud PO, (2009) The blood-brain barrier in brain homeostasis and neurological diseases. BBA-Biomembranes 1788: 842-857.
7. Dudley AC, (2012) Tumor endothelial cells. Cold Spring Harb Perspect Med 2: a006536.
8. Deeken JF, Loescher W, (2007) The blood-brain barrier and cancer: Transporters, treatment, and Trojan horses. Clin Cancer Res 13: 1663-1674.
9. Black KL, Ningaraj NS, (2004) Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11: 165-173.
10. Cao Y, Tsien CL, Shen Z, Tatro DS, Ten Haken R, et al. (2005) Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol 23: 4127-4136.
11. Cloughesy TF, Black KL, (1995) Pharmacological blood-brain barrier modification for selective drug delivery. J Neurooncol 26: 125-132.
12. Baumann BC, Kao GD, Mahmud A, Harada T, Swift J, et al. (2013) Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy. Oncotarget 4: 64-79.
13. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, et al. (2010) Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Bioph Res Co 393: 649-655.
14. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD, (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1: 325-327.
15. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, et al. (2008) Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 8: 4593-4596.
16. Kim D, Park S, Lee JH, Jeong YY, Jon S, (2007) Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J Amer Chem Soc 129: 7661-7665.
17. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM, (2006) Gold nanoparticles: a new x-ray contrast agent. Brit J Radiol 79: 248-253.
18. Cai Q-Y, Kim SH, Choi KS, Kim SY, Byun SJ, et al. (2007) Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol 42: 797-806.
19. Jain PK, El-Sayed IH, El-Sayed MA, (2007) Au nanoparticles target cancer. Nano Today 2: 18-29.
20. Gibson JD, Khanal BP, Zubarev ER, (2007) Paclitaxel-functionalized gold nanoparticles. J Amer Chem Soc 129: 11653-11661.
21. Albanese A, Tang PS, Chan WCW, (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14: 1-16.
22. Liu CJ, Wang CH, Chien CC, Yang TY, Chen ST, et al. (2008) Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification. Nanotechnology 19: 295104.
23. Liu CJ, Wang CH, Chen ST, Chen HH, Leng WH, et al. (2010) Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 55: 931-945.
24. Hainfeld JF, Slatkin DN, Smilowitz HM, (2004) The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49: N309-N315.
25. Hainfeld JF, Dilmanian FA, Zhong Z, Slatkin DN, Kalef-Ezra JA, et al. (2010) Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 55: 3045-3059.
26. Zhang XD, Wu D, Shen X, Chen J, Sun Y-M,et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33: 6408-6419.
27. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, et al. (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21: 10644-10654.
28. Huo S, Ma H, Huang K, Liu J, Wei T, et al. (2012) Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res 73: 319-330.
29. Kimling J, Maier M, Okenve B, Kotaidis V, Ballot H, et al. (2006) Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 110: 15700-15707.
30. Turkevich J, Stevenson PC, Hillier J, (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 11: 55-75.
31. Radaelli E, Ceruti R, Patton V, Russo M, Degrassi A, et al. (2009) Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. Histol Histopathol 24: 879-891.
32. Baumann BC, Dorsey JF, Benci JL, Joh DY, Kao GD Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. J Vis Exp 67: e4089.
33. Ozawa T, James CD (2010) Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging. J Vis Exp: e1986.
34. Hou YN, Lavaf A, Huang D, Peters S, Huq R, et al. (2009) Development of an automated gamma-h2ax immunocytochemistry assay. Radiat Res 171: 360-367.
35. Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, et al. (2012) An integrated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain tumors using the small animal radiation research platform. Trans Oncol 5: 230-237.
36. Pricker S, (1996) Medical uses of gold compounds: Past, present and future. Gold Bull 29: 53-60.
37. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, et al. (2010) Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31: 2034-2042.
38. Goel R, Shah N, Visaria R, Paciotti GF, Bischof JC, (2009) Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine 4: 401-410.
39. James W, Hirsch L, West J, O'Neal P, Payne J, (2007) Application of INAA to the build-up and clearance of gold nanoshells in clinical studies in mice. J Radioanal Nucl Chem 271: 455-459.
40. Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, et al. (2009) Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5: 162-169.
41. Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, et al. (2010) Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16: 6139-6149.
42. Cho WS, Cho M, Jeong J, Choi M, Han BS, et al. (2010) Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245: 116-123.
43. Zhang X-D, Wu D, Shen X, Liu P-X, Yang N, et al. (2011) Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine 6: 2071-2081.
44. Jain S, Hirst DG, O'Sullivan JM, (2012) Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85: 101-113.
45. Lechtman E, Chattopadhyay N, Cai Z, Mashouf S, Reilly R, et al. (2011) Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol 56: 4631-4647.
46. Butterworth KT, McMahon SJ, Currell FJ, Prise KM, (2012) Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 4: 4830-4838.
47. McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, et al. (2011) Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci Rep 1: 18.
48. Chithrani DB, Jelveh S, Jalali F, van Prooijen M, Allen C, et al. (2010) Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 173: 719-728.
49. Ngwa W, Makrigiorgos GM, Berbeco RI, (2010) Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Phys Med Biol 55: 6533-6548.
50. Berbeco RI, Ngwa W, Makrigiorgos GM, (2011) Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage x-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int. J. Radiat. Oncol 81: 270-276.
51. Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, et al. (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18: 829-834.
52. Jin YD, Jia CX, Huang SW, O'Donnell M, Gao XH, (2010) Multifunctional nanoparticles as coupled contrast agents. Nat Commun 1: 41.
53. Park JA, Reddy PAN, Kim HK, Kim IS, Kim GC, et al. (2008) Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent. Bioorgan Med Chem Lett 18: 6135-6137.
54. Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, et al. (2011) Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Onc 79: 531-539.
55. Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, et al. (2009) Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomed-Nanotechnol 5: 136-142.
56. Chattopadhyay N, Cai Z, Pignol JP, Keller B, Lechtman E, et al. (2010) Design and characterization of HER-2-targeted gold nanoparticles for enhanced x-radiation treatment of locally advanced breast cancer. Mol Pharm 7: 2194-2206.
57. Machein MR, Plate KH, (2000) VEGF in Brain Tumors. J Neurooncol 50: 109-120.
58. Ngwa W, Makrigiorgos GM, Berbeco RI, (2012) Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration. Phys Med Biol 57: 6371-6380.